Gestational diabetes mellitus (GDM) poses significant risks to both mother and child, necessitating a comprehensive management approach. This article aims to elucidate such an approach to optimize patient outcomes.
Early detection and diagnosis are paramount in managing GDM. Universal screening between 24-28 weeks of gestation using an oral glucose tolerance test is recommended. Additionally, high-risk individuals should be screened at the first prenatal visit.
Medical nutrition therapy (MNT) is the cornerstone of GDM management. It involves individualized meal planning to achieve euglycemia, adequate nutrition, and appropriate weight gain. Regular dietetic consultations are essential to monitor progress and adjust the plan as necessary.
Physical activity complements MNT in achieving glycemic control. Unless contraindicated, pregnant women should aim for at least 150 minutes of moderate-intensity aerobic activity weekly, distributed over at least three days.
If MNT and physical activity fail to achieve glycemic targets within one to two weeks, pharmacological therapy should be initiated. Insulin is the first-line treatment, but oral hypoglycemic agents like metformin and glyburide are increasingly used.
Postpartum follow-up is crucial as GDM increases the risk of type 2 diabetes. A 75g oral glucose tolerance test should be performed at 6-12 weeks postpartum, followed by lifelong screening for diabetes at least every three years.
GDM management requires a comprehensive approach encompassing early detection, MNT, physical activity, pharmacological therapy, and postpartum follow-up. By adopting such a strategy, healthcare professionals can optimize outcomes for both mother and child, mitigating the risks associated with GDM.
1.
Scholastic performance is a key concern for young cancer patients, study finds
2.
With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.
3.
Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet
4.
PRO Data Strengthen Case for Dato-DXd in First-Line TNBC
5.
Study looks into cancer-related harmful communication.
1.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
2.
Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances
3.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
4.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
5.
Risk Assessment of Cancer-Associated Thrombotic Events
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
Oropharyngeal Cancer in Relation to HPV Status
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation